AC

Aisling Capital Portfolio holdings

AUM $45.3M
This Quarter Return
+13.51%
1 Year Return
-15.24%
3 Year Return
+386.13%
5 Year Return
+1,047.82%
10 Year Return
AUM
$506M
AUM Growth
+$506M
Cap. Flow
-$136M
Cap. Flow %
-26.8%
Top 10 Hldgs %
99.69%
Holding
14
New
Increased
Reduced
4
Closed
2

Top Buys

No buys this quarter

Sector Composition

1 Healthcare 68.68%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
LOXO
1
DELISTED
Loxo Oncology, Inc
LOXO
$289M 57.19% 3,438,920 -750,000 -18% -$63.1M
AIMT
2
DELISTED
Aimmune Therapeutics, Inc.
AIMT
$84.7M 16.74% 2,240,000 -750,000 -25% -$28.4M
VRAY
3
DELISTED
ViewRay, Inc.
VRAY
$69.3M 13.69% 7,480,887
ASXC
4
DELISTED
Asensus Surgical, Inc.
ASXC
$19.1M 3.77% 9,889,352 -446,467 -4% -$862K
ENTL
5
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
$12.9M 2.55% 528,655
ADMA icon
6
ADMA Biologics
ADMA
$4.12B
$11.6M 2.29% 3,608,171
CDTX icon
7
Cidara Therapeutics
CDTX
$1.66B
$6.94M 1.37% 1,021,148
SYRS
8
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$4.95M 0.98% 508,565
AGRX
9
DELISTED
Agile Therapeutics, Inc
AGRX
$3.51M 0.69% 1,304,933 -500,000 -28% -$1.34M
CMRX
10
DELISTED
Chimerix, Inc.
CMRX
$2.19M 0.43% 472,943
PTX
11
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$504K 0.1% 210,000
ESPR icon
12
Esperion Therapeutics
ESPR
$448M
-837,125 Closed -$42M
ZLTQ
13
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
-11,985 Closed